PMC:7534795 / 112422-112722 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T76","span":{"begin":26,"end":34},"obj":"Body_part"},{"id":"T77","span":{"begin":242,"end":247},"obj":"Body_part"}],"attributes":[{"id":"A76","pred":"fma_id","subj":"T76","obj":"http://purl.org/sig/ont/fma/fma62851"},{"id":"A77","pred":"fma_id","subj":"T77","obj":"http://purl.org/sig/ont/fma/fma67264"}],"text":" potential effects on the platelet aggregation in severe cases of SARS-CoV-2 infected subjects. Our current level of knowledge only permits speculation on whether n-3 PUFAs can mitigate the coagulopathy associated with severe COVID-19.\n\n8.7 Lipid-lowering properties of n-3 PUFAs in the context of C"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T612","span":{"begin":66,"end":74},"obj":"Disease"},{"id":"T613","span":{"begin":190,"end":202},"obj":"Disease"},{"id":"T614","span":{"begin":226,"end":234},"obj":"Disease"}],"attributes":[{"id":"A612","pred":"mondo_id","subj":"T612","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A613","pred":"mondo_id","subj":"T613","obj":"http://purl.obolibrary.org/obo/MONDO_0001531"},{"id":"A614","pred":"mondo_id","subj":"T614","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" potential effects on the platelet aggregation in severe cases of SARS-CoV-2 infected subjects. Our current level of knowledge only permits speculation on whether n-3 PUFAs can mitigate the coagulopathy associated with severe COVID-19.\n\n8.7 Lipid-lowering properties of n-3 PUFAs in the context of C"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T17989","span":{"begin":167,"end":172},"obj":"Chemical"},{"id":"T64723","span":{"begin":242,"end":247},"obj":"Chemical"},{"id":"T97641","span":{"begin":275,"end":280},"obj":"Chemical"}],"attributes":[{"id":"A93304","pred":"chebi_id","subj":"T17989","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A75360","pred":"chebi_id","subj":"T64723","obj":"http://purl.obolibrary.org/obo/CHEBI_18059"},{"id":"A60345","pred":"chebi_id","subj":"T97641","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":" potential effects on the platelet aggregation in severe cases of SARS-CoV-2 infected subjects. Our current level of knowledge only permits speculation on whether n-3 PUFAs can mitigate the coagulopathy associated with severe COVID-19.\n\n8.7 Lipid-lowering properties of n-3 PUFAs in the context of C"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T35","span":{"begin":26,"end":46},"obj":"http://purl.obolibrary.org/obo/GO_0070527"}],"text":" potential effects on the platelet aggregation in severe cases of SARS-CoV-2 infected subjects. Our current level of knowledge only permits speculation on whether n-3 PUFAs can mitigate the coagulopathy associated with severe COVID-19.\n\n8.7 Lipid-lowering properties of n-3 PUFAs in the context of C"}

{"project":"LitCovid-sentences","denotations":[{"id":"T691","span":{"begin":96,"end":235},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" potential effects on the platelet aggregation in severe cases of SARS-CoV-2 infected subjects. Our current level of knowledge only permits speculation on whether n-3 PUFAs can mitigate the coagulopathy associated with severe COVID-19.\n\n8.7 Lipid-lowering properties of n-3 PUFAs in the context of C"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T253","span":{"begin":190,"end":202},"obj":"Phenotype"}],"attributes":[{"id":"A253","pred":"hp_id","subj":"T253","obj":"http://purl.obolibrary.org/obo/HP_0003256"}],"text":" potential effects on the platelet aggregation in severe cases of SARS-CoV-2 infected subjects. Our current level of knowledge only permits speculation on whether n-3 PUFAs can mitigate the coagulopathy associated with severe COVID-19.\n\n8.7 Lipid-lowering properties of n-3 PUFAs in the context of C"}

{"project":"LitCovid-PubTator","denotations":[{"id":"3172","span":{"begin":26,"end":46},"obj":"Disease"},{"id":"3173","span":{"begin":66,"end":85},"obj":"Disease"},{"id":"3174","span":{"begin":190,"end":202},"obj":"Disease"},{"id":"3175","span":{"begin":226,"end":234},"obj":"Disease"},{"id":"3178","span":{"begin":242,"end":247},"obj":"Chemical"}],"attributes":[{"id":"A3172","pred":"tao:has_database_id","subj":"3172","obj":"MESH:D001791"},{"id":"A3173","pred":"tao:has_database_id","subj":"3173","obj":"MESH:C000657245"},{"id":"A3174","pred":"tao:has_database_id","subj":"3174","obj":"MESH:D001778"},{"id":"A3175","pred":"tao:has_database_id","subj":"3175","obj":"MESH:C000657245"},{"id":"A3178","pred":"tao:has_database_id","subj":"3178","obj":"MESH:D008055"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" potential effects on the platelet aggregation in severe cases of SARS-CoV-2 infected subjects. Our current level of knowledge only permits speculation on whether n-3 PUFAs can mitigate the coagulopathy associated with severe COVID-19.\n\n8.7 Lipid-lowering properties of n-3 PUFAs in the context of C"}